Sarepta Therapeutics (SRPT) Gross Margin Growth (3y) (2020 - 2026)

Sarepta Therapeutics (SRPT) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -230.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -168.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 193,280.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 589.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 6.06 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 53.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 569.00
10 Sarepta Therapeutics 1.91 Bn 1.12 Bn 251.87 Mn -2,417.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,417.00
Mar 31, 2026 24.00
Dec 31, 2025 -8,646.00
Sep 30, 2025 -2,040.00
Jun 30, 2025 -707.00
Mar 31, 2025 -8,652.00
Dec 31, 2024 -233.00
Sep 30, 2024 8,459.00
Jun 30, 2024 -38.00
Mar 31, 2024 298.00
Dec 31, 2023 1,134.00
Sep 30, 2023 40.00
Jun 30, 2023 -335.00
Mar 31, 2023 -402.00
Dec 31, 2022 1,199.00
Sep 30, 2022 -419.00
Jun 30, 2022 -108.00
Mar 31, 2022 -279.00
Dec 31, 2021 -220.00
Sep 30, 2021 -9,308.00